Found: 18
Select item for more details and to access through your institution.
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00834-6
- By:
- Publication type:
- Article
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00392-1
- By:
- Publication type:
- Article
Characteristics and outcomes of five patients with COVID-19 and hematological malignancies.
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 6, p. 1, doi. 10.1002/ccr3.4013
- By:
- Publication type:
- Article
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 8, p. 1270, doi. 10.1002/cncr.35156
- By:
- Publication type:
- Article
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 11, p. 1704, doi. 10.1002/cncr.34722
- By:
- Publication type:
- Article
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic‐phase myelofibrosis.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 13, p. 2449, doi. 10.1002/cncr.34216
- By:
- Publication type:
- Article
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 356, doi. 10.1111/bjh.17192
- By:
- Publication type:
- Article
Cancer Treatment Closer to the Patient Reduces Travel Burden, Time Toxicity, and Improves Patient Satisfaction, Results of 546 Consecutive Patients in a Northern Italian District.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 12, p. 2121, doi. 10.3390/medicina59122121
- By:
- Publication type:
- Article
Correlation between Subpubic Arch Angle and Mode of Delivery in Large-for-Gestational-Age Fetuses.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5027, doi. 10.3390/cancers15205027
- By:
- Publication type:
- Article
Safety and efficacy of granulocyte colony-stimulating factor biosimilars in engraftment after autologous stem cell transplantation for haematological malignancies: a 4-year, single institute experience with different conditioning regimens.
- Published in:
- Blood Transfusion (17232007), 2015, v. 13, n. 3, p. 478, doi. 10.2450/2015.0198-14
- By:
- Publication type:
- Article
Fetal head circumference and subpubic angle are independent risk factors for unplanned cesarean and operative delivery.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article